Application 210786
- Type
- ANDA
- Sponsor
- NOVAST LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NADOLOL | NADOLOL | TABLET;ORAL | 20MG | No | No |
| 002 | NADOLOL | NADOLOL | TABLET;ORAL | 40MG | No | No |
| 003 | NADOLOL | NADOLOL | TABLET;ORAL | 80MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210786-001 | NADOLOL | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | ||
| A210786-002 | NADOLOL | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | ||
| A210786-003 | NADOLOL | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210786-002 | NADOLOL | 40MG | TABLET / ORAL | 2018-06-01 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210786-003 | NADOLOL | 80MG | TABLET / ORAL | 2018-06-01 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A210786-001 | NADOLOL | 20MG | TABLET / ORAL | 2018-06-01 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A210786-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A210786-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A210786-003 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210786-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210786-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210786-003 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A210786-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A210786-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A210786-003 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A210786-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A210786-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A210786-003 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A210786-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210786-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210786-003 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A210786-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A210786-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A210786-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A210786-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A210786-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A210786-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A210786-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A210786-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A210786-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nadolol | NADOLOL | A-S Medication Solutions | 4580b85b-437c-4c52-bf31-5976968ecd5c | 2026-06-19 | Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Bryant Ranch Prepack | c154d99c-e4fb-41d0-8fac-e1982672e8d7 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | BluePoint Laboratories | f11553f1-18ec-41b0-a7ad-1c9f21ef2c9f | 2026-05-20 | Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | REMEDYREPACK INC. | 8a224f90-24a5-411e-ac26-6496a1930f3a | 2026-05-18 | Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Amneal Pharmaceuticals NY LLC | e2e24b14-0169-4028-828a-894ad3c2ba55 | 2026-05-12 | Warnings, Adverse reactions | Nadolol NADOLOL |
| NADOLOL | NADOLOL | Bryant Ranch Prepack | 64a788d0-b7f0-4f39-8adb-ab68870ecfa5 | 2026-04-29 | Warnings, Adverse reactions | NADOLOL NADOLOL |
| Nadolol | NADOLOL | Bryant Ranch Prepack | 2d126308-c58d-4950-9dcb-eaadb1a2054f | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Golden State Medical Supply, Inc. | 33dcfdb9-1741-71e1-e063-6294a90afdff | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | UNICHEM PHARMACEUTICALS (USA), INC. | 5a8014fb-9b65-4457-bfd5-0ab7e6de330e | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | American Health Packaging | 9acc0c81-4145-43cc-b31a-7b1e3313259d | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | American Health Packaging | 9e8e129d-cb17-45fc-b3e2-2600c0166463 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | BluePoint Laboratories | 15822faf-6924-4a63-a4e1-6058b308708c | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Zydus Lifesciences Limited | 29433c5a-51c6-4fb9-9174-1b1c616c9e57 | 2024-12-05 | Nadolol NADOLOL | |
| Nadolol | NADOLOL | Bryant Ranch Prepack | 0d66548a-231e-4104-be0c-c6ce1586b46c | 2024-10-02 | Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | BluePoint Laboratories | 0a2acdc0-aab6-462e-a377-67a0f3d55ec6 | 2024-05-28 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Bryant Ranch Prepack | 2fc1f850-9653-4082-929a-926b644810e7 | 2024-01-26 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Bryant Ranch Prepack | 9cf4ca73-2d38-44c2-a522-d44d536b5e55 | 2024-01-26 | Boxed warning, Warnings, Adverse reactions | Nadolol NADOLOL |
| Nadolol | NADOLOL | Aurobindo Pharma Limited | 44c5352d-89f8-4bd3-9479-1069304562ca | 2024-01-10 | Warnings, Adverse reactions | Nadolol NADOLOL |
| NADOLOL | NADOLOL | Alembic Pharmaceuticals Inc. | 6ab029aa-dfe0-4abb-8c7f-2692fe6a2368 | 2024-01-08 | Warnings, Adverse reactions | NADOLOL NADOLOL |
| Nadolol | NADOLOL | Zydus Pharmaceuticals USA Inc. | a0a38f9b-268d-4463-881d-5bee6cd92e8a | 2024-01-02 | Warnings, Adverse reactions | Nadolol NADOLOL |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50742-178 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-178 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-178 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-179 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-179 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-179 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-180 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-180 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-180 | NADOLOL | nadolol | Ingenus Pharmaceuticals, LLC | ANDA | Current |